Kōmmour Prenatal for Prenatal Health Disparities among Marshallese Pregnant Women
Trial Summary
What is the purpose of this trial?
The purpose of the study is to culturally adapt and examine the feasibility of a group prenatal program (Kōmmour Prenatal) to reduce maternal and infant health disparities among Marshallese Pacific Islander women in the US. The study will also gather information from providers of Kōmmour Prenatal and stakeholders in the Marshallese community familiar with the program to learn of their experience with the program.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Kōmmour Prenatal for improving prenatal health among Marshallese pregnant women?
How is the Kōmmour Prenatal treatment different from other prenatal care options for Marshallese women?
Research Team
Britni Ayers, PhD
Principal Investigator
University of Arkansas for Medical Sciences Northwest
Eligibility Criteria
This trial is for Marshallese women who are at least 18 years old and between 8-20 weeks pregnant. It aims to help reduce health issues for mothers and babies by adapting a group prenatal program specifically for their community.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the Kōmmour Prenatal program to reduce maternal and infant health disparities
Follow-up
Participants are monitored for outcomes such as gestational weight gain, breastfeeding initiation, and birth weight of infant
Treatment Details
Interventions
- Kōmmour Prenatal
Kōmmour Prenatal is already approved in United States for the following indications:
- Reducing maternal and infant health disparities among Marshallese Pacific Islander women
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arkansas
Lead Sponsor